First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,560.40 -21.20 (-1.34%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. PRSM, TRST, KAPE, KNOS, LTG, GBG, ATG, ALFA, IMO, and CERShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Trustpilot Group (TRST), Kape Technologies (KAPE), Kainos Group (KNOS), Learning Technologies Group (LTG), GB Group (GBG), Auction Technology Group (ATG), Alfa Financial Software (ALFA), IMImobile (IMO), and Cerillion (CER). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Blue Prism Group Trustpilot Group Kape Technologies Kainos Group Learning Technologies Group GB Group Auction Technology Group Alfa Financial Software IMImobile Cerillion Blue Prism Group (LON:PRSM) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Does the MarketBeat Community favor PRSM or FBT? Blue Prism Group received 71 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. Likewise, 69.08% of users gave Blue Prism Group an outperform vote while only 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote. CompanyUnderperformOutperformBlue Prism GroupOutperform Votes14369.08% Underperform Votes6430.92% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes7266.67% Underperform Votes3633.33% Does the media favor PRSM or FBT? In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation'saverage media sentiment score. Company Overall Sentiment Blue Prism Group Neutral First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Is PRSM or FBT more profitable? Company Net Margins Return on Equity Return on Assets Blue Prism GroupN/A N/A N/A First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A Which has higher earnings & valuation, PRSM or FBT? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlue Prism Group£167.30M0.00N/A-£53.80N/AFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,418.55 SummaryBlue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 4 of the 5 factors compared between the two stocks. Remove Ads Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£640.10M£5.08B£22.93B£2.61BDividend YieldN/A3.06%2.81%4.82%P/E Ratio-1,418.5526.3742.06141.37Price / SalesN/A273.672,065.36283,838.46Price / Cash3.5416.8734.7128.10Price / BookN/A9.176.094.63Net IncomeN/A£65.07M£739.25M£5.82B7 Day Performance-2.29%0.95%-2.04%1.44%1 Month Performance-8.80%-3.11%49,802.62%7.38%1 Year Performance4.33%0.64%52,860.17%112.64% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,560.40-1.3%N/A+5.8%£640.10MN/A-1,418.5520PRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeTRSTTrustpilot Group2.6927 of 5 starsGBX 234.50+2.6%GBX 335+42.9%+18.2%£1.23B£222.55M77.73820Insider TradeNews CoverageGap UpHigh Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Positive NewsGap DownKNOSKainos Group2.9776 of 5 starsGBX 721+0.6%GBX 1,150+59.5%-28.3%£910.70M£383.18M18.892,953Gap DownHigh Trading VolumeLTGLearning Technologies Group2.0825 of 5 starsGBX 99.80flatGBX 90-9.8%+17.0%£791.30M£529.20M16.745,001News CoverageGBGGB Group2.1888 of 5 starsGBX 307.60+1.3%GBX 395+28.4%+10.9%£775.85M£276.95M-15.971,183Positive NewsHigh Trading VolumeATGAuction Technology Group0.8605 of 5 starsGBX 583+1.4%GBX 680+16.6%-2.6%£720.21M£136.68M71.21396Analyst ForecastNews CoverageHigh Trading VolumeALFAAlfa Financial SoftwareN/AGBX 228+2.2%N/A+31.3%£682.81M£103.11M30.82475High Trading VolumeIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300CERCerillion0.977 of 5 starsGBX 1,570+4.0%GBX 1,682.50+7.2%-0.6%£465.59M£41.39M33.09321Dividend IncreasePositive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Blue Prism Group Competitors Trustpilot Group Competitors Kape Technologies Competitors Kainos Group Competitors Learning Technologies Group Competitors GB Group Competitors Auction Technology Group Competitors Alfa Financial Software Competitors IMImobile Competitors Cerillion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.